Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Ken Nagashima is active.

Publication


Featured researches published by Ken Nagashima.


FEBS Letters | 1991

Inhibition of nerve growth factor-induced neurite outgrowth of PC12 cells by a protein kinase inhibitor which does not permeate the cell membrane

Ken Nagashima; Satoshi Nakanishi; Yuzuru Matsuda

K‐252a, a protein kinase inhibitor of microbial origin, has proven to be a specific inhibitor of nerve growth factor. In this study, the effects of K‐252b, the 9‐carboxylic acid derivative of K‐252a, on nerve growth factor‐induced neurite outgrowth in PC12 cells was examined. K‐252b is hydrophilic and does not permeate the cell membrane of PC12 cells, whereas K‐252a clearly does. K‐252b is, however, as potent as K‐252a itself in inhibiting the nerve growth factor‐induced neurite outgrowth. These results can be interpreted to suggest that effects of K‐252b may be through surface‐bound/anchored K‐252b‐sensitive molecules on PC12 cells.


Journal of Pharmacy and Pharmacology | 2003

Protective effects of benidipine on hydrogen peroxide-induced injury in rat isolated hearts.

Kozo Yao; Yasuhiro Ina; Rie Sonoda; Ken Nagashima; Kenji Ohmori; Tetsuji Ohno

We investigated the effects of benidipine (hydrochloride), a calcium antagonist, on hydrogen peroxide (H2O2)‐induced injury in Langendorff‐perfused rat hearts. The hearts were aerobically perfused at a constant flow and exposed to H2O2 (600 μmol L−1) for 4 min, resulting in the oxidative stress‐induced myocardial dysfunction (e.g., decrease in the left ventricular developed pressure) and myocardial cell injury (e.g., increase in the release of lactate dehydrogenase). Pretreatment of the hearts with benidipine or nifedipine was performed for 20 min until the start of H2O2 exposure. Benidipine at 1 nmol L−1 and nifedipine at 10 nmol L−1 decreased the myocardial contractility and perfusion pressure to a similar degree in the hearts under normal conditions. Benidipine (1 nmol L−1) significantly reduced the H2O2‐induced myocardial damage. Nifedipine (10 nmol L−1) also tended to exhibit similar effects. Benidipine inhibited the increase in tissue lipid peroxidation induced by H2O2. The results suggest that, in addition to the calcium antagonism, benidipine possesses other actions responsible for the cardioprotective effects, to which the antioxidant activity of benidipine may partly contribute.


Journal of Pharmacy and Pharmacology | 2000

Benidipine Inhibits Apoptosis During Ischaemic Acute Renal Failure in Rats

Kozo Yao; Hitoshi Sato; Yasuhiro Ina; Ken Nagashima; Satoshi Nishikawa; Kenji Ohmori; Tetsuji Ohno

We have investigated the effects of benidipine (hydrochloride), a calcium antagonist, against ischaemic acute renal failure in rats. Using histological examination, we studied whether the inhibition of apoptosis was associated with the protective effects of benidipine on the ischaemic renal injury.


Journal of Pharmacological Sciences | 2006

Pharmacological, Pharmacokinetic, and Clinical Properties of Benidipine Hydrochloride, a Novel, Long-Acting Calcium Channel Blocker

Kozo Yao; Ken Nagashima; Hiroyuki Miki


Biological & Pharmaceutical Bulletin | 2000

Antioxidant effects of calcium antagonists in rat brain homogenates

Kozo Yao; Yazuhiro Ina; Ken Nagashima; Kenji Ohmori; Tetsuji Ohno


Journal of Medicinal Chemistry | 1996

Studies of Cardiotonic Agents. 8. Synthesis and Biological Activities of Optically Active 6-(4-(Benzylamino)-7-quinazolinyl)-4,5-dihydro-5-methyl- 3(2H)-pyridazinone (KF15232)

Yuji Nomoto; Haruki Takai; Tetsuji Ohno; Ken Nagashima; Kozo Yao; Koji Yamada; Kazuhiro Kubo; Michio Ichimura; and Akira Mihara; Hiroshi Kase


Japanese Journal of Pharmacology | 2000

New approach for measurement of sympathetic nervous abnormality in conscious, spontaneously hypertensive rats.

Makoto Tsunoda; Kazuko Takezawa; Tomofumi Santa; Yasuhiro Ina; Ken Nagashima; Kenji Ohmori; Satoshi Kobayashi; Kazuhiro Imai


Proceedings of the Japan Academy Series B: Physical and Biological Sciences | 1999

Attenuation of methylation of catecholamines and treatment with a coenzyme of catechol-O-methyltransferase in spontaneously hypertensive rats (SHR)

Kazuhiro Imai; Makoto Tsunoda; Kazuko Takezawa; Kazuto Mitsuhashi; Tomofumi Santa; Ken Nagashima; Keishi Katayama; Kenji Ohmori


Archive | 1998

Preventive and remedy for drug-induced nephropathy

Junichi Shimada; Fumio Suzuki; Ken Nagashima; Hiroko Okano; Akira Karasawa


The Journal of Antibiotics | 1993

Neurite formation in NG108-15 neuroblastoma × glioma hybrid cells by KS-505a, a potent inhibitor of brain cyclic nucleotide phosphodiesterase

Ken Nagashima; Shinichiro Toki; Satoshi Nakanishi; Hiroshi Kase; Yuzuru Matsuda

Collaboration


Dive into the Ken Nagashima's collaboration.

Top Co-Authors

Avatar

Tetsuji Ohno

University of Pittsburgh

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Koji Yamada

College of Industrial Technology

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Fumio Suzuki

University of Wisconsin-Madison

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge